A new Yale-led study has for the first time identified which risk factors are more likely to trigger a heart attack or acute myocardial infarction (AMI) for men and women 55 years and younger.
May 4, 2022
0
94
Percutaneous coronary intervention (PCI) does not reduce all-cause mortality or heart failure hospitalization in patients with severe left ventricular dysfunction and extensive coronary artery disease, according to late breaking ...
Aug 29, 2022
0
13
A cohort study of more than 9,000 persons found that in asymptomatic middle-aged persons without known cardiovascular disease, subclinical, obstructive coronary atherosclerosis is associated with a more than 8-fold elevated ...
Mar 27, 2023
0
28
The immunosuppressant drug cyclosporine did not improve clinical outcomes compared to placebo in patients receiving percutaneous coronary intervention (PCI) for the more severe form of heart attack known as ST-segment elevation ...
Aug 30, 2015
0
47
New research presented at this year's annual meeting of the European Association for the Study of Diabetes in Stockholm shows that diabetic women are more at risk than diabetic men of having a heart attack and other complications ...
Sep 14, 2015
0
12
Mediterranean and low fat dietary programs reduce the likelihood of death and heart attack in patients at heightened risk of cardiovascular disease, finds the first comparative review based on randomized trials of seven popular ...
Mar 29, 2023
0
37
(HealthDay)—Gestational diabetes mellitus (GDM) is associated with an increased risk for diverse cardiovascular outcomes later in life, according to a study presented at the annual meeting of the Society for Maternal-Fetal ...
Feb 10, 2022
0
3
For people with obesity, the impact of losing or gaining weight on serious health problems depends on their starting body mass index (BMI), according to a study in over 400,000 adults with obesity in primary care across the ...
May 4, 2022
0
8
Patients undergoing percutaneous coronary intervention (PCI), a coronary artery widening procedureused to treat heart disease, are at high risk for obstructive sleep apnea (OSA), according to new research presented at the ...
May 18, 2015
0
41
A clinical trial comparing prasugrel to clopidogrel for patients with high on-clopidogrel platelet reactivity (HCPR) following percutaneous coronary intervention (PCI) was ended early due to relatively few occurrences of ...
Nov 9, 2011
0
0
